Sort   by:  
 Page size 
UnknownRemdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Not available
S-EPMC7054408 | biostudies-literature
UnknownIn vitro and in vivo inhibition of the host TRPC4 channel attenuates Zika virus infection.
Not available
S-EPMC11319825 | biostudies-literature
UnknownComparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro.
Not available
S-EPMC7481761 | biostudies-literature
UnknownLDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB).
Not available
S-EPMC9184653 | biostudies-literature
UnknownPathological features of COVID-19-associated liver injury-a preliminary proteomics report based on clinical samples.
Not available
S-EPMC7791959 | biostudies-literature
UnknownIn vitro and in vivo efficacy of Molnupiravir against Zika virus infections.
Not available
S-EPMC10436044 | biostudies-literature
ProteomicsIntegrated Proteomics Characterization of SARS-CoV-2 Associated Liver Injury
The high incidence of liver injury in patients with COVID-19 and the need for long-term medication for recovery make it imperative to study the infectivity and pathogenicity of SARS-CoV-2 in the liver. Here, we have identified significant proteomic changes for the first time in the liver of patients...
ORGANISM(S): Homo Sapiens 
PXD019968 |
ProteomicsIntegrated Proteogenomic Characterization of Medullary Thyroid Carcinoma
Global proteome data for 102 MTC samples, and phosphoproteome data for 74 MTC samples
ORGANISM(S): Homo Sapiens 
PXD032887 |
Sort   by:  
 Page size